Method of inhibiting osteoclast-mediated bone resorption by admi

Details Method of inhibiting osteoclast-mediated bone resorption by admi Method of inhibiting osteoclast-mediated bone resorption by admi

1991-08-09

1993-06-08

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

514486, 514487, 514613, 514557, 514561, 514570, 514572, 514899, A61K 3127, A61K 3116, A61K 3119

Patent

active

052179940

ABSTRACT:
Compounds of the general formula ##STR1## and the pharmaceutically acceptable salts thereof wherein

REFERENCES:
patent: 4258062 (1981-03-01), Jonas et al.
patent: 4812304 (1989-03-01), Anderson et al.
patent: 4822817 (1989-04-01), Oremo et al.
patent: 4970238 (1990-11-01), Louis et al.
Journal of Cell Biology, vol. 111 (1990) by Sato, et al.
Journal of Bone and Mineral Research, vol. 5 No. 1, pp. 31-40 (1990), Sato, et al.
Bone, 9, 73-79 (1988), Kanasaha, et al.

Affiliated with

Also associated with

Rating

Method of inhibiting osteoclast-mediated bone resorption by admi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting osteoclast-mediated bone resorption by admi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting osteoclast-mediated bone resorption by admi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1934344